Journal: Frontiers in Pharmacology
Article Title: GTX-11 attenuates lung fibrosis, inflammation and vascular remodeling in preclinical models of lung fibrotic disease
doi: 10.3389/fphar.2025.1671132
Figure Lengend Snippet: Comparative effects of GTX-11m and approved antifibrotic therapies on fibrotic marker induction in hNLFs. Gene expression levels of relevant fibrotic markers COL1A1, MMP2, ACTA2, FN and TNC , after incubations with TGFβ1 and GTX-11m (5 μM), nintedanib (1 μM), pirfenidone (1 mM), R-268712 (1 μM) or the indicated combinations for 48h (n = 5). Bars show mean ± SD. Mixed-effects analysis with Dunnett’s correction for multiple comparisons was performed in all graphs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Article Snippet: Nintedanib and pirfenidone were both purchased from MedChemExpress (HY-50904 and HY-B0673).
Techniques: Marker, Gene Expression